COPD and Asthma Devices Market Report by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Channel (Retail Pharmacies, Hospitals, Online Pharmacies), and Region 2025-2033

The global COPD and asthma devices market size reached USD 47.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 70.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.42% during 2025-2033. The market growth is primarily driven by continual technological advancements in smart inhalers with real-time monitoring capabilities, growing prevalence of respiratory conditions, an enhanced emphasis on personalized treatment options for more accurate drug delivery and increasing demand in emerging markets due to improved healthcare access.

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.

COPD and Asthma Devices Market Trends:

The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices. Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth. The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome. Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global COPD and asthma devices market report, along with forecasts at the global, regional, and country level from 2025-2033. Our report has categorized the market based on product, indication and distribution channel.

Breakup by Product:

• Inhalers
• Drug Powdered Inhalers (DPIs)
• Metered Dose Inhalers (MDIs)
• Soft Mist Inhalers
• Nebulizers
• Compressor Nebulizers
• Ultrasonic Nebulizers
• Mesh Nebulizers

Breakup by Indication:

• Asthma
• COPD

Breakup by Distribution Channel:

• Retail Pharmacies
• Hospitals
• Online Pharmacies

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.

Key Questions Answered in This Report

1.What was the size of the global COPD and asthma devices market market in 2024?

2.What is the expected growth rate of the global COPD and asthma devices market during 2025-2033?

3.What are the key factors driving the global COPD and asthma devices market?

4.What has been the impact of COVID-19 on the global COPD and asthma devices market?

5.What is the breakup of the global COPD and asthma devices market based on the product?

6.What is the breakup of the global COPD and asthma devices market based on the indication?

7.What is the breakup of the global COPD and asthma devices market based on distribution channel?

8.What are the key regions in the global COPD and asthma devices market?

9.Who are the key players/companies in the global COPD and asthma devices market?